• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070300-33
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Pseudoaneurysm (2605)
Event Date 04/13/2019
Event Type  Injury  
Manufacturer Narrative
Date of event: estimated dates.The device was not returned for evaluation.A review of the lot history record of the reported device could not be conducted because the lot number was not provided.The reported patient effects of pseudoaneurysm and angina is listed in the xience xpedition everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The 2.5x18 mm xience xpedition stent referenced is filed under a separate medwatch report number.Literature attachment.Article title: a case report of a coronary artery aneurysm as a rare complication of percutaneous coronary intervention.
 
Event Description
It was reported in a research article that the procedure was to treat multi-vessel disease.For treatment of the mid left anterior descending (lad), pre-dilatation was performed and a 3.0x33 mm xience xpedition stent was implanted at the proximal part.Because of residual stenosis in the mid part, another 2.5x18 mm xience xpedition stent was implanted.The patient was discharged in good condition.Six weeks later, the patient experienced chest pain and angiography showed a pseudoaneurysm in the mid portion of the lad at the site of the previous stenting.Bypass graft surgery was performed to resolve the pseudoaneurysm and treat the patient's coronary artery disease.No additional information was provided.For full details, see attached article titled: "a case report of a coronary artery aneurysm as a rare complication of percutaneous coronary intervention.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11394264
MDR Text Key234215319
Report Number2024168-2021-01560
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIR
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number1070300-33
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/04/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age60 YR
-
-